BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 4274502)

  • 1. Spontaneous regression of malignant melanoma. Pathologic and immunologic study in a ten year survivor.
    Maurer H; McIntyre OR; Rueckert F
    Am J Surg; 1974 Apr; 127(4):397-403. PubMed ID: 4274502
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunology of human malignant melanoma.
    Lewis MG
    Ser Haematol; 1972; 5(5):44-65. PubMed ID: 4598040
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunology and cutaneous malignant melanoma.
    Sober AJ
    Int J Dermatol; 1976; 15(1):1-18. PubMed ID: 1107238
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-specific and specific immunotherapy in patients with melanoma.
    Seigler HF; Shingleton WW; Metzgar RS; Buckley CE; Bergoc PM; Miller DS; Fetter BF; Phaup MB
    Surgery; 1972 Jul; 72(1):162-74. PubMed ID: 4555924
    [No Abstract]   [Full Text] [Related]  

  • 5. [Vaccination therapy of melanoma].
    Schuler-Thurner B; Schuler G
    J Dtsch Dermatol Ges; 2005 Aug; 3(8):630-45. PubMed ID: 16033483
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunological aspects in malignant melanoma].
    Macher E
    Arch Dermatol Forsch; 1972; 244():234-9. PubMed ID: 4675197
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunotherapy].
    Lejeune FJ; Bernheim JL; Vanwijck R
    Acta Chir Belg; 1974 Mar; 73(2):265-93. PubMed ID: 4450923
    [No Abstract]   [Full Text] [Related]  

  • 8. Current concepts of the biology of human cutaneous malignant melanoma.
    Clark WH; Mastrangelo MJ; Ainsworth AM; Berd D; Bellet RE; Bernardino EA
    Adv Cancer Res; 1977; 24():267-338. PubMed ID: 322460
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term spontaneous regression of malignant melanoma with visceral metastases. Report of a case with immunologic profile.
    Bulkley GB; Cohen MH; Banks PM; Char DH; Ketcham AS
    Cancer; 1975 Aug; 36(2):485-94. PubMed ID: 1157014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical histologic, and immunologic study of a case of metastatic malignant melanoma undergoing spontaneous remission.
    Bodurtha AJ; Berkelhammer J; Kim YH; Laucius JF; Mastrangelo MJ
    Cancer; 1976 Feb; 37(2):735-42. PubMed ID: 943226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The characterization of tumour-associated membrane-bound antigens and their implementation in the treatment of malignant melanoma (author's transl)].
    Kokoschka EM
    Wien Klin Wochenschr Suppl; 1979; 97():3-32. PubMed ID: 106559
    [No Abstract]   [Full Text] [Related]  

  • 12. Viral oncolysate in the management of malignant melanoma. I. Preparation of the oncolysate and measurement of immunologic responses.
    Cassel WA; Murray DR; Torbin AH; Olkowski ZL; Moore ME
    Cancer; 1977 Aug; 40(2):672-9. PubMed ID: 196739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multiphase immunotherapy regimen for human melanoma: clinical and laboratory results.
    Levy NL; Seigler HF; Shingleton WW
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1548-57. PubMed ID: 4421918
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical experiences in immunotherapy of cancer.
    Krementz ET; Samuels MS; Wallace JH; Benes EN
    Surg Gynecol Obstet; 1971 Aug; 133(2):209-17. PubMed ID: 5284416
    [No Abstract]   [Full Text] [Related]  

  • 15. Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma.
    Eton O; Kharkevitch DD; Gianan MA; Ross MI; Itoh K; Pride MW; Donawho C; Buzaid AC; Mansfield PF; Lee JE; Legha SS; Plager C; Papadopoulos NE; Bedikian AY; Benjamin RS; Balch CM
    Clin Cancer Res; 1998 Mar; 4(3):619-27. PubMed ID: 9533529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
    Mittelman A; Chen GZ; Wong GY; Liu C; Hirai S; Ferrone S
    Clin Cancer Res; 1995 Jul; 1(7):705-13. PubMed ID: 9816036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant melanoma.
    Moore GE; Gerner RE
    Surg Gynecol Obstet; 1971 Mar; 132(3):427-36. PubMed ID: 5546295
    [No Abstract]   [Full Text] [Related]  

  • 18. Intralesional BCG in the treatment of metastatic malignant melanoma.
    Mastrangelo MJ; Sulit HL; Prehn LM; Bornstein RS; Yarbro JW; Prehn RT
    Cancer; 1976 Feb; 37(2):684-92. PubMed ID: 766947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses induced by human malignant melanoma in the rabbit.
    Goodwin DP; Hornung MO; Leong SP; Krementz ET
    Surgery; 1972 Nov; 72(5):737-43. PubMed ID: 4117015
    [No Abstract]   [Full Text] [Related]  

  • 20. Malignant melanoma and its therapy: a review.
    Chanda JJ; Callen JP; Stawiski MA
    Cutis; 1979 Jun; 23(6):759-83. PubMed ID: 380931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.